These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17893961)

  • 1. [Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():7-9. PubMed ID: 17893961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary deficiencies of humoral immunity in hematology: what management?].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():1. PubMed ID: 17893958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults].
    Frydecka I
    Postepy Hig Med Dosw; 2002; 56 Suppl():53-8. PubMed ID: 12661415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
    Raanani P; Gafter-Gvili A; Paul M; Ben-Bassat I; Leibovici L; Shpilberg O
    Leuk Lymphoma; 2009 May; 50(5):764-72. PubMed ID: 19330654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic lymphoid leukemia and intravenous immunoglobulins].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():2-4. PubMed ID: 17893959
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multiple myeloma and intravenous immunoglobulins].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():5-6. PubMed ID: 17893960
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary antibody deficiencies.
    Dhalla F; Misbah SA
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):505-13. PubMed ID: 26406183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of infection in patients with B cell defects: focus on intravenous immunoglobulin.
    Yap PL
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S372-5. PubMed ID: 8274603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of myeloma in a chronic lymphocytic leukemia patients after response to differentiation therapy with interleukin-4.
    Makower D; Venkatraj U; Dutcher JP; Wiernik PH
    Leuk Lymphoma; 1996 Nov; 23(5-6):617-9. PubMed ID: 9031095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.
    Visentin A; Compagno N; Cinetto F; Imbergamo S; Zambello R; Piazza F; Semenzato G; Trentin L; Agostini C
    Haematologica; 2015 Dec; 100(12):e515-8. PubMed ID: 26294735
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma.
    Thürmann PA; Sonnenburg C; Valentová K; Gregora E; Freischläger F; Lissner R
    Eur J Clin Pharmacol; 2001 Jun; 57(3):235-41. PubMed ID: 11497339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
    Newcom SR
    N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia and multiple myeloma in the same patient: case report.
    Aktan M; Akkaya A; Doğan O; Dincol G
    Leuk Lymphoma; 2003 Aug; 44(8):1421-4. PubMed ID: 12952239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.
    Winkelstein A; Jordan PS
    Clin Rev Allergy; 1992; 10(1-2):39-58. PubMed ID: 1606523
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
    Besa EC
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
    [No Abstract]   [Full Text] [Related]  

  • 17. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
    Castelli R; Vismara A; Pavia G; Dagani R; Porro T
    Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
    Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
    Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin.
    Brenner B
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S115-9. PubMed ID: 8828958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.